(0.37%) 5 110.25 points
(0.79%) 38 685 points
(0.64%) 17 764 points
(0.14%) $79.06
(-0.34%) $2.03
(-0.05%) $2 308.40
(-0.22%) $26.77
(1.26%) $974.70
(-0.12%) $0.931
(-0.65%) $10.92
(-0.17%) $0.797
(0.50%) $91.59
4.76% HKD 0.330
Live Chart Being Loaded With Signals
China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong...
Stats | |
---|---|
Volumen de hoy | 115 000 |
Volumen promedio | 173 782 |
Capitalización de mercado | 317.87M |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0.0100 ( 2023-05-19 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -3.30 |
ATR14 | HKD0 (0.00%) |
China Biotech Services Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
China Biotech Services Finanzas
Annual | 2023 |
Ingresos: | HKD211.99M |
Beneficio Bruto: | HKD34.32M (16.19 %) |
EPS: | HKD-0.0991 |
FY | 2023 |
Ingresos: | HKD211.99M |
Beneficio Bruto: | HKD34.32M (16.19 %) |
EPS: | HKD-0.0991 |
FY | 2022 |
Ingresos: | HKD1.85B |
Beneficio Bruto: | HKD1.10B (59.46 %) |
EPS: | HKD0.730 |
FY | 2021 |
Ingresos: | HKD623.76M |
Beneficio Bruto: | HKD358.02M (57.40 %) |
EPS: | HKD0.0200 |
Financial Reports:
No articles found.
China Biotech Services Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0100 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.395 | 2004-08-19 |
Last Dividend | HKD0.0100 | 2023-05-19 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | HKD0.405 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.81 | -- |
Div. Sustainability Score | 1.007 | |
Div.Growth Potential Score | 2.93 | |
Div. Directional Score | 1.969 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2628.HK | Ex Dividend Junior | 2023-07-05 | Annually | 0 | 0.00% | |
1402.HK | Ex Dividend Junior | 2023-08-10 | Sporadic | 0 | 0.00% | |
0467.HK | Ex Dividend Junior | 2023-07-18 | Annually | 0 | 0.00% | |
6858.HK | Ex Dividend Knight | 2023-09-20 | Semi-Annually | 0 | 0.00% | |
1958.HK | Ex Dividend Knight | 2023-06-28 | Annually | 0 | 0.00% | |
0987.HK | Ex Dividend Junior | 2023-06-23 | Annually | 0 | 0.00% | |
0097.HK | Ex Dividend Junior | 2023-06-07 | Semi-Annually | 0 | 0.00% | |
3331.HK | Ex Dividend Knight | 2023-08-18 | Semi-Annually | 0 | 0.00% | |
1553.HK | Ex Dividend Junior | 2023-06-09 | Annually | 0 | 0.00% | |
0590.HK | Ex Dividend Knight | 2023-08-22 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.535 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.186 | 1.200 | -6.21 | -7.45 | [0 - 0.3] |
returnOnEquityTTM | -0.198 | 1.500 | -3.31 | -4.97 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.638 | 0.800 | 6.81 | 5.45 | [1 - 3] |
quickRatioTTM | 1.543 | 0.800 | 5.63 | 4.50 | [0.8 - 2.5] |
cashRatioTTM | 1.297 | 1.500 | 3.90 | 5.85 | [0.2 - 2] |
debtRatioTTM | 0.152 | -1.500 | 7.47 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -34.51 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.200 | 2.00 | 9.93 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.200 | 2.00 | 9.90 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.217 | -1.500 | 9.13 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0995 | 1.000 | -1.675 | -1.675 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.796 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.918 | 1.000 | 0.455 | 0.455 | [0.2 - 2] |
assetTurnoverTTM | 0.348 | 0.800 | -1.015 | -0.812 | [0.5 - 2] |
Total Score | 1.007 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -2.62 | 1.000 | -0.365 | 0 | [1 - 100] |
returnOnEquityTTM | -0.198 | 2.50 | -2.13 | -4.97 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.200 | 2.00 | 9.93 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.99 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.200 | 2.00 | 9.93 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.836 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 2.93 |
China Biotech Services
China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through five segments: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, Insurance brokerage, and Others segments. It also engages in the research, development, manufacture, sale, and distribution of health related and pharmaceutical products; trading of securities; money lending business; provision of tumor immune cell therapy, immune cell storage, and health management services; and provision of coordination of healthcare providers services. In addition, the company markets and sells health supplements, slimming pills, Chinese medicines, and beauty products; trades in pharmaceutical intermediates; and offers insurance brokerage services. Further, it provides property investment and logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico